SUSAN BLANEY to Receptors, Vascular Endothelial Growth Factor
This is a "connection" page, showing publications SUSAN BLANEY has written about Receptors, Vascular Endothelial Growth Factor.
Connection Strength
0.173
-
A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium report. Clin Cancer Res. 2012 Sep 15; 18(18):5081-9.
Score: 0.097
-
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors. Pediatr Blood Cancer. 2009 Feb; 52(2):169-76.
Score: 0.076